Statin adherence and health outcomes after st-elevation myocardial infarction: 1-year follow-up study

A Padilla López1

  • 1Servicio de Farmacia de Área, Departamento de Salud de Valencia Clínico-Malvarrosa, Valencia, Spain.

Insights

Statin adherence after ST-elevation myocardial infarction (STEMI) significantly reduces cardiovascular mortality. Monitoring adherence beyond initial prescription is crucial for improving patient outcomes in the first year post-STEMI.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Dyslipidemia control post-ST-elevation myocardial infarction (STEMI) is often inadequate despite high statin prescription rates.
  • Assessing statin treatment adherence and its impact on cardiovascular outcomes is vital for optimizing secondary prevention.
  • Understanding factors influencing adherence can guide interventions to improve patient management after STEMI.

Purpose of the Study:

  • To estimate statin treatment adherence rates in patients following a first type 1 STEMI.
  • To identify demographic and clinical factors associated with statin adherence.
  • To evaluate the impact of statin adherence on cardiovascular mortality and new vascular events within the first year post-STEMI.

Main Methods:

  • Retrospective observational study of 552 patients hospitalized with STEMI between 2008 and 2013.
  • Statin adherence measured by proportion of days covered (PDC).
  • Binary logistic regression and competing risk analysis used to assess relationships between adherence, patient characteristics, and cardiovascular outcomes.

Main Results:

  • Lower adherence observed in foreign nationals, smokers, and patients with hepatic impairment.
  • Higher adherence noted in patients ≥50 years, pensioners, and those with dyslipidemia, obesity, or kidney failure.
  • Statin adherence was associated with a significant reduction in cardiovascular mortality (HR 0.201, p=0.001) but not new vascular events (p=0.834).

Conclusions:

  • Statin adherence in the first year after STEMI is a critical determinant of mortality.
  • Assessment of statin adherence should extend beyond initial prescription to ensure sustained patient benefit.
  • Improving statin adherence is a key strategy for reducing mortality in STEMI survivors.
Abstract

Related Concept Videos

Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
72
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
207
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
69
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.1K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
62